NEW XELLIA GROUP A/S
Global leader in fermentation-based anti-infective pharmaceutical manufacturing and supply.
Oversigt
- 37
- Medarbejdere
- Ukendt
- Omsætning
- 2013
- Grundlagt
Nøglebeslutningstagere
Steen Riisgaard
Chairman of the Board
Michael Kocher
Chief Executive Officer
Julie McHugh
Board Member
Vicente Oller
Chief Financial Officer
+11 flere kontakter i Funnelfeedr
Beskrivelse
Xellia Pharmaceuticals is a global leader in the development and manufacturing of fermentation-based, non-beta-lactam anti-infective medicines. With a rich legacy spanning over 120 years, the company provides essential Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs) to more...